Peptides
Beyond Weight Loss: The Expanding Clinical Map of GLP-1s
New 2025 data suggests GLP-1 receptor agonists are doing more than shrinking waistlines — with signals across the brain, kidneys, and operating room. Here's what the evidence actually says.